SNN Smith & Nephew
- 25.745
- -0.025-0.10%
Smith & Nephew News
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
Telecoms stocks led European equities traded in the US as American depositary receipts slightly higher Tuesday morning, rising 0.15% to 1,420.65 on the S&P Europe Select ADR Index. From continental Eu
Negative Pressure Wound Therapy (NPWT) Market Analysis, 2023-2030, Featuring 3M, Medela, Smith & Nephew, Convatec, Talley Group - Rising Usage of Simplified Single-Use NPWT Devices
Bio-Implants - A $223 Billion Global Market Opportunity by 2031 With LifeNet Health, Smith & Nephew, Arthrex, Clinic Lemanic, and Alpha Bio Tec Dominating the Competition
Global and Regional Film Dressings Industry Research 2023-2024 & 2030 - Smith & Nephew, 3M, and Medline Industries Lead Competitive Landscape
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by $3 to $27,
Smith & Nephew Logs Higher Q1 Revenue; FY24 Guidance Affirmed
Smith & Nephew (SN.L) on Wednesday reported a year-over-year increase to its revenue in the first quarter. The medical technology group's revenue for the three months ended March 30 was nearly $1.39 b
Smith & Nephew Confident in Outlook in All Three of Business Units
Smith & Nephew Confident in Outlook in All Three of Business Units
Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%
Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%
Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B
02:08 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B
Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis
Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis
Smith & Nephew Saw Continued Weakness in US Hip and Knee Implants
Smith & Nephew Saw Continued Weakness in US Hip and Knee Implants
Smith & Nephew 1Q Rev $1.39B
Smith & Nephew 1Q Rev $1.39B
Smith & Nephew Plc Backs 2024 View
Smith & Nephew Plc Backs 2024 View
Europe Scar Management Market Analysis Report 2024: A $350+ Million Market by 2030 With Advancis Medical, Bayer, B. Braun, Molnlycke Health Care, Smith & Nephew, and Stratpharma Dominating
With 83% Ownership of the Shares, Smith & Nephew Plc (LON:SN.) Is Heavily Dominated by Institutional Owners
Smith+Nephew Announces New Evidence Supporting ALLEVYN LIFE Foam Dressing's Role in Pressure Injury Prevention
Smith+Nephew (NYSE:SNN, LSE:SN)), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the
Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.
Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal
Proxy advisers cautioned Smith & Nephew (SN.L) shareholders regarding a new pay policy as part of a plan to reduce turnover of the company's executives. Institutional Shareholder Services urged shareh
JPMorgan's Top European Picks
JPMorgan analysts published their list of top European stocks.
Smith+Nephew Signs Exclusive Distribution Agreement to Provide Unique NAVBIT SPRINT Solution in Australia
Analysis
Price Target
No Data
